Cargando…
Using Whole Genome Sequencing in an African Subphenotype of Myasthenia Gravis to Generate a Pathogenetic Hypothesis
Myasthenia gravis (MG) is a rare, treatable antibody-mediated disease which is characterized by muscle weakness. The pathogenic antibodies are most frequently directed at the acetylcholine receptors (AChRs) at the skeletal muscle endplate. An ophthalmoplegic subphenotype of MG (OP-MG), which is char...
Autores principales: | Nel, Melissa, Mulder, Nicola, Europa, Tarin A., Heckmann, Jeannine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406016/ https://www.ncbi.nlm.nih.gov/pubmed/30881381 http://dx.doi.org/10.3389/fgene.2019.00136 |
Ejemplares similares
-
Gene expression profiling of orbital muscles in treatment-resistant ophthalmoplegic myasthenia gravis
por: Europa, Tarin A., et al.
Publicado: (2020) -
Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases
por: Europa, Tarin A., et al.
Publicado: (2022) -
The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review
por: Heckmann, Jeannine M., et al.
Publicado: (2022) -
Profiling of patient-specific myocytes identifies altered gene expression in the ophthalmoplegic subphenotype of myasthenia gravis
por: Nel, Melissa, et al.
Publicado: (2019) -
Immune-Related Molecular Profiling of Thymoma With Myasthenia Gravis
por: Zhuang, Jinman, et al.
Publicado: (2021)